We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Nanotechnology Efficiently Unzips DNA for Quick and Easy Genetic Testing

By LabMedica International staff writers
Posted on 31 Jul 2025

Understanding our genetic makeup requires decoding the DNA double helix, a structure that must first be carefully “unzipped” to reveal its sequence. More...

Traditional DNA denaturation techniques rely on intense heating and chemical processes, which are not only energy-intensive but can also damage delicate DNA molecules. These methods are slow, require the entire sample to be heated, and reduce the precision of downstream analysis. Accurate and efficient unzipping of DNA is essential for personalized genomics, yet current technologies fall short in providing quick, non-destructive, and power-efficient solutions. Now, a new technology offers a way to unzip DNA gently and precisely using localized heat, allowing for the real-time reading of individual DNA strands without damaging them.

A nanotechnology-based system, developed by researchers at The University of Osaka (Osaka, Japan), addresses these challenges using a microscopic platinum coil heater integrated into a nanopore device. As DNA approaches the nano-sized pore, the voltage applied to the coil produces heat, locally unzipping the double helix and enabling single-strand reading. A significant benefit of this approach is its energy efficiency—it requires just a few milliwatts of power to operate. The device allows for precise control over the unzipping process, including the timing and speed, while minimizing DNA damage. This is achieved by regulating the molecule’s movement through the pore using electrical signals and observing its interaction with surrounding forces like fluid drag and temperature. These insights are key to further advancing nanopore-based DNA sequencing technologies.

The new method was validated using a long viral DNA molecule of nearly 50,000 base pairs and a smaller circular plasmid. In both cases, only minimal heat was needed to initiate unzipping. The results, published in ACS Nano, demonstrate how the device enables fine-tuned, real-time control of DNA strand separation. Its compact, low-power design holds promise for integration into portable diagnostic tools, paving the way for on-site genetic testing. Such tools could revolutionize personalized medicine by rapidly identifying disease-causing genes and supporting treatment decisions tailored to a person’s unique genetic profile. Researchers aim to refine the system for broader clinical and research applications, potentially transforming how genetic data is accessed and utilized in healthcare.

“Our device should be easy to manufacture and, we hope, will become a core technology for fast and accurate next-generation sequencing. The device is microscopic and consumes very little power, so it could potentially be incorporated into portable diagnostic devices, allowing on-site access to genetic information that can guide diagnosis and treatment,” said Tomoji Kawai, senior author and professor at The University of Osaka.

Related Links:
University of Osaka 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.